Masteron 100 (DP 100) Drostanolone Propionate Oil Steroids Injectable 100mg/ml

Description

Masteron Drostanolone DHT Derivative Injectable Research

Specification Sheet

• CAS Number: 521-12-0
• Molecular Formula: C23H36O3
• Molecular Weight: 360.53 g/mol
• Appearance: Clear to pale yellow viscous solution
• Purity: >99% confirmed via HPLC-UV
• Solubility: Miscible in organic solvents and carrier lipids (Grapeseed Oil, Ethyl Oleate)

How It Works

The pharmacology of Drostanolone Propionate is defined by its structural resistance to metabolic deactivation and its high binding affinity for the androgen receptor. Drostanolone Propionate acts as a high-affinity ligand for the nuclear Androgen Receptor (AR), promoting immediate translocation into the nucleus. The 2-methyl modification inhibits the 3α-hydroxysteroid dehydrogenase enzyme, ensuring the molecule remains biologically active within skeletal muscle tissue rather than being reduced to inactive metabolites. The Propionate ester regulates the rate of intramuscular liberation from the lipid depot, providing a terminal half-life of roughly 48-72 hours. Unlike Testosterone, Masteron cannot be converted to estrogen, and binding kinetics suggest it may competitively inhibit the aromatase enzyme, thereby reducing systemic estrogenic signaling.

Overview

Drostanolone Propionate, often identified by the research moniker Masteron, is a 2-methylated derivative of dihydrotestosterone (DHT) engineered for high anabolic efficiency without the risk of aromatization. This synthetic androgen facilitates rapid receptor saturation through a short-chain ester delivery system. Researchers utilize this compound to investigate myogenic regulatory factors and the modulation of estrogenic environments in advanced biological models.

Research Observations

• Enhanced Myofibrillar Density: Research models indicate a profound increase in muscle hardness and ‘dryness’ due to zero fluid retention.
• Androgenic Signaling: Based on community feedback, effects include a significant boost in neurological drive and muscular force production.
• Anti-Estrogenic Modulation: Experimental findings suggest a reduction in subcutaneous water retention and improved vascularity in low-body-fat models.
• Lipolysis Stimulation: Research models indicate that high AR affinity facilitates the down-regulation of adipocyte gene expression.
• Positive Nitrogen Balance: Observed effects include sustained protein synthesis rates even during periods of caloric restriction.

In Brief:
Drostanolone Propionate serves as a high-precision research tool for studying pure androgenic signaling and aesthetic tissue refinement with rapid pharmacokinetic clearance.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.